Overview

Efficacy and Safety of Different Doses of Indacaterol

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Salmeterol Xinafoate